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The present study was conducted to determine if vitamin E and selenium could have a
positive synergistic effect during experimental Chagas' disease. In the first phase of the
study, 25 female C3HeB/FeJ mice were infected with a Brazil strain of Trypanosoma cruzi
while receiving vitamin E supplementation of 0 IU/kg, 200 IU/kg, 400 IU/kg, 600 IU/kg,
800 IU/kg in their diets. In the second phase, 20 female C3HeB/FeJ mice were infected
while receiving 400 IU/kg vitamin E plus selenium supplementation of 2 ppm, 4 ppm, 8
ppm, 16 ppm in their drinking water. The results demonstrate that vitamin E does have a
protective effect during experimental Chagas' disease. There was a statistically significant
difference (p<0.05) observed between the vitamin E-deficient mice and mice supplemented
with vitamin E. The results of this study also suggest that combined vitamin E and selenium
supplementation provides an even greater benefit than either antioxidant alone in mice
infected with T. cruzi. A statistically significant difference was observed (p<0.01) between
vitamin E supplemented mice and mice supplemented with vitamin E and selenium. The
beneficial effects observed included: reduced parasitemia, increased survival rate, and
reduced weight loss during infection. In this study, the combination of 400 IU/kg vitamin E
Vlll

and 8 ppm selenium provided the best overall protective effect during experimental Chagas'
disease.
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BACKGROUND
Trypanosoma cruzi
The flagellated protozoan, Trypanosoma cruzi, causes Chagas' disease or American
trypanosomiasis in humans. The parasite is distributed throughout most of South and
Central America, where it infects 16 to 18 million people and kills approximately 45,000
through heart failure annually (Kirchhoff, 1993). Each year in Brazil alone, several
thousand people die of heart and digestive problems brought on by the disease (Marshall,
1995). In the United States, T. cruzi has been reported from wild mammals in Maryland,
Georgia, Florida, Texas, Arizona, New Mexico, California, Alabama, Louisiana (Kagan et
al., 1966) and North Carolina (Karsten et al., 1992). Many kinds of wild and domestic
mammals serve as reservoirs. Animals that live in proximity to humans, such as dogs, cats,
opossums, armadillos, and wood rats are particularly important in the epidemiology of
Chagas' disease. This disease also can be transmitted by blood transfusion (Wendel and
Gonzaga, 1993). For almost 40 years, this form of transmission has been limited to Latin
America, but recently, with increasing emigration to North America and Europe, Chagas'
disease may be introduced to the northern hemisphere by transfusion of blood obtained
from asymptomatic carriers (Kirchhoff, 1993). It has been estimated that there are
100,000 individuals living in the United States who are chronically infected with T. cruzi
(Schmunis, 1991). In Argentina, Brazil, and Chile, 14 to 18 percent of new infections are
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acquired from the transfusion of infected blood; and in Bolivia, approximately 49 percent
of new infections are due to transfusion (Schmunis, 1991). Thus, transfusion acquired T.
cruzi infection is a serious problem that is no longer restricted to Latin American
countries.
T. cruzi is a stercorarian trypanosome. In its life cycle, there are three forms trypomastigote, epimastigote and amastigote. The trypomastigote form is found in the
circulating blood of the mammalian host. It is slender, 12 to 20 (im long, and its posterior
end is pointed (Wendel and Gonzaga, 1993). The free flagellum is moderately long, and
the undulating membrane is narrow, with only two or three undulations at a time along its
length. The kinetoplast is subterminal and is the largest of any trypanosome; it sometimes
causes the body to bulge around it. The amastigote stage develops in muscles and other
tissues. Amastigotes are spheroid, 1.5 to 4.0 |im wide, and occur in clusters composed of
many organisms (Wendel and Gonzaga, 1993). The epimastigote form is found in the gut
of its insect host. Epimastigotes have a juxtanuclear kinetoplast and a flagellum (Wendel
and Gonzaga, 1993).
T. cruzi is transmitted as an infective metacyclic trypomastigote form to mammalian
hosts via the insect vector's feces. The vectors of T. cruzi are the hematophagous bugs of
the family Reduviidae. The three genera of this family that are important in the spread of
the human disease are Panstrongylus, Triatoma and Rhodnius (Wendel and Gonzaga,
1993). Following feeding by the vector, metacyclic trypanosomes enter the mammalian
host either through the puncture wound or through nearby mucous membranes. Once
inside the body, the metacyclics do not divide extracellularly but enter macrophages or
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nearby tissue cells in a polarized and probably active manner (Schenkman et al., 1988),
escape from the lysosomal compartment into the cytoplasm, and transform into rounded
amastigotes. Intracellular division occurs several times by binary fission and the infected
cells rupture. The parasites are released as tissue-derived trypomastigotes which are
capable of infecting surrounding cells or disseminating to other tissues via the
bloodstream. Characteristically, muscle and neuronal tissues of all types are most heavily
parasitized. The T. cruzi life-cycle is completed when blood-form trypomastigotes are
taken up during feeding by the reduviid bugs. In the insect midgut, the trypomastigote
become short epimastigotes, which multiply by longitudinal fission to become long,
slender epimastigotes. Short metacyclic trypomastigotes appear in the insect rectum 8 to
10 days following infection (Roberts and Janovy, 1996). These infective stages can then be
voided in the feces during a blood meal.
Pathogenesis
Chagas' disease is manifested in both acute and chronic phases. The acute phase is
initiated by inoculation of trypomastigotes deposited by the feeding vector. The local
inflammation produces a small red nodule, known as a chagoma, accompanied by swelling
of the regional lymph nodes. In about 50% of the cases the trypanosomes enter through
the conjunctiva of the eye, causing edema of the eyelid and conjunctiva and swelling of the
preauricular lymph node, known as Romana's sign (Roberts and Janovy, 1996). As the
acute phase progresses, pseudocysts may be found in almost any organ of the body. The
heart muscle is usually invaded, with up to 80% of the cardiac ganglion cells being lost
(Roberts and Janovy, 1996). Symptoms of the acute phase include anemia, loss of
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strength, nervous disorders, chills, muscle and bone pain, and varying degrees of heart
failure. Death may ensue three to four weeks after infection (Roberts and Janovy, 1996).
The acute stage is most common and severe among children less than five years old.
The chronic stage; however, is most often seen in adults. The spectrum of symptoms seen
in the chronic phase is primarily the result of central and peripheral nervous dysfunction,
which may last for many years. Some patients may be virtually asymptomatic and then
suddenly succumb to heart failure. Chagas' disease accounts for about 70% of cardiac
deaths in young adults in endemic areas (Roberts and Janovy, 1996). Part of the
inefficiency in heart function is caused by loss of muscle tone resulting from the destroyed
nerve ganglia. The heart itself becomes greatly enlarged and flabby.
Most infections last the life of the individual, but severity of the acute infection may
determine the course of the chronic disease, possibly by affecting the type of immune
response involved. Host and parasite genetic makeup, sex, age, prior infection, and a
variety of other factors influence disease development and the relationship between these
factors is still unresolved (Roberts and Janovy, 1996).
Host - parasite relationship
Trypanosoma cruzi can presumably infect all mammals and is transmitted to
mammalian hosts in the feces of infected reduviid vectors as these insects take a blood
meal. T. cruzi is an obligate intracellular parasite and resides most commonly within host
striated muscle cells, fibroblasts and macrophages. Infection with T. cruzi gives rise to an
immune response in humans and in other animals; this immune response is both humoral
and cell- mediated (Kuhn, 1989).
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A severe non-specific immunosuppression mediated by T cells and macrophages
occurs following T. cruzi infection (Cardillo et al., 1996). In murine model systems of
acute Chagas' disease, this state of immunosuppression has been shown to be associated
with significant reduction of interleukin-2 (IL-2) production and suppressed expression of
IL-2 receptor (IL-2R) molecules by activated lymphocytes (Majumder and Kierszenbaum,
1996).
Chronic infections are controlled primarily by humoral responses, and in some
mouse/parasite strain combinations circulating IgG is protective (Roberts and Janovy,
1996). Natural killer cells and cytotoxic T lymphocytes are capable of lysing infected host
cells, while activated macrophages, neutrophils and eosinophils may destroy
trypomastigotes during cell-mediated responses (Kuhn, 1989).
Cytokine control is important in T. cruzi infection. Transforming growth factor-P
(TGF-P) is activated by the parasite and has potent inhibitory effects on macrophage
function (Reed, 1995). IL-10 produced by T cells, B cells and macrophages following T.
cruzi infection downregulates macrophage activation (Reed, 1995). In contrast,
Interferon-y (IFN-y), granulocyte macrophage colony-stimulatory factor (GM-CSF) and
IL-2 protect the mammalian host from T. cruzi infection.
The most intimate interaction in this host-parasite relationship occurs by direct
contact of the parasites with host cells; this contact, leading to subsequent internalization,
is essential to the survival of the parasite. A recent study performed with cultured
mammalian cells has shown that T. cruzi invasion is an unusual process that depends on
parasite energy and on negatively charged surface molecules of the host cell (Burleigh and
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Andrews, 1995). Several surface glycoproteins and mucin-like molecules of
trypomastigotes were implicated primarily by inhibition studies with antibodies in
interaction with host cells. Several of the trypomastigote surface glycoproteins have been
shown to be related to members of a large family that includes the T. cruzi trans-sialidase.
The mucin-like molecules are a separate family of threonine-rich, O-glycosylated
molecules that function as acceptors of sialic acid in the infective stage (Burleigh and
Andrews, 1995). It has been suggested that parasite surface molecules mediate binding to
host cells, whereas invasion of nonphagocytic cells involves recruitment of host-cell
lysosomes, an unusual event apparently triggered by signal transduction (Rodriguez et al.,
1996).
Antioxidant nutrients and disease prevention
The possibility of a relationship in human subjects between diet and chronic or acute
disease has been a major preoccupation of nutritional and medical scientists throughout a
long period of history. Various constituents of food have been seen both as preventive and
causative factors in the etiogenesis of disease. Activated oxygen often causes damage in
living organisms and it may be the origin of a variety of diseases (Diplock, 1991). The
defense of living eukaryotic cells against this damage is a complex process that involves a
battery of interrelated protective agents. Antioxidant nutrients lie functionally at the heart
of this protective mechanism. They include the minerals selenium, copper, zinc, and
manganese, and vitamin E, C and probably A, as well as P-carotene (Diplock, 1991).
Often, as a by-product of metabolism, reactive metabolites of oxygen, such as singlet
oxygen and free radicals, are formed. They can attack DNA, protein and polyunsaturated
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phospholipids, and have potential detrimental effects in living systems. Therefore, it is
necessary to remove such substances from the system as soon as they are formed. A free
radical is defined as an atom or molecule that has one or more unpaired electron(s)
(Diplock, 1991). Among various free radicals in living systems the hydroxyl radical is very
highly reactive and potentially severely damaging because it can pull an electron from
almost any organic molecule in its vicinity, which will initiate further radical or nonradical
processes that may lie at the heart of the etiogenesis of biochemical changes that will lead
to disease (Diplock, 1991). The hydroxyl radical is the product of the initial metabolites superoxide anion and hydrogen peroxide. The control of generation of hydroxyl radical
depends on the removal of these two metabolites. The superoxide anion radical is
efficiently removed in the mitochondrial compartment by superoxide dismutase (SOD),
which in this location is a manganese-containing enzyme, while in the cytosolic
compartment the SOD is copper and zinc dependent (Diplock, 1991). Hydrogen peroxide
is metabolized in both intracellular compartments by glutathione peroxidase, which is a
selenium-containing enzyme (Diplock, 1991). Thus, the control of the initiation of free
radical-mediated intracellular damage depends on the presence of these enzymes. In turn,
the activity of these enzymes depends on the nutritional availability of the so-called
antioxidant minerals, manganese, copper, zinc and selenium. Any deficiency in these
nutrients may thus lower the level of the antioxidant defense mechanism so that disease
processes will be initiated.
Vitamin C, vitamin E and P-carotene are important in human cellular protection
because of their antioxidant functions. As with all antioxidants, there is the potential for
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formation of their own radical species during the processes by which highly reactive free
radicals are quenched. However, the so-called pro-oxidant forms of these substances are
much less reactive and have lower energy levels than the free radicals that they neutralize
(Deshpande et al., 1996). Thus, the reactivity of antioxidants in pro-oxidant form is much
less than that of the harmful radicals associated with damage to tissues and organs of the
body (Deshpande et al., 1996). Therefore, the antioxidant functions of micronutrients are
the attributes that are most biologically relevant.
Non-antioxidant mechanisms of antioxidant vitamins also play a role in disease
prevention. For example, the action of vitamin E in regulating membrane fluidity and
stabilization, 5-lipoxygenase activity and protein kinase C activity are all activities
independent of the capacity to scavenge free radicals (Blumberg, 1995).
Mounting evidence from laboratory and human studies points to the potential
efficacy of antioxidants in reducing the risk of some cancers, cardiovascular diseases,
cataracts and infectious diseases as well as injury from pro-oxidant environmental
pollutants such as smog and cigarette smoke. Also, antioxidants prevent aging,
inflammation and autoimmune disease (Deshpande et al., 1996).
The immune system is responsible for protection against infection by invading
pathogens such as bacteria, viruses, fungi, and protozoan parasites. Cells of the immune
system are highly dependent on a functioning cell membrane for secretion of lymphokines
and antibodies, antigen recognition, lymphocyte transformation, and contact cell lysis.
Certain cells of the immune system produce and use free radicals and reactive oxygen
molecules, especially during the early stage of infection (Deshpande et al., 1996).
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However, if these reactive species are over-produced during this process, they may injure
the immune cells themselves as well as neighboring cells and tissues. Certain
environmental factors, such as UV light, cigarette smoke and environmental pollutants can
decrease immune functions. Thus, antioxidants are very necessary to keep the immune
system functioning properly. Many researchers have suggested that supplementation of
diets with vitamin C or E or P-carotene provides a safe and effective means to enhance
clinically relevant immune functions (reviewed by Blumberg, 1995).
Vitamin E
Vitamin E, an essential fat-soluble vitamin, includes eight naturally occurring
compounds in two classes designated as tocopherols and tocotrienols with different
biological activities. The tocopherol designated as a-tocopherol has the highest biological
activity and is the most widely available form of vitamin E in food (Meydani, 1995). The
other isomers (p, y, 8), some of which are more abundant in a typical western diet, are
less biologically active than a-tocopherol. The commercially available synthetic forms of
vitamin E are comprised of approximately an equal mixture of eight stereoisomeric forms
of a-tocopherol (Meydani, 1995). Usually, the amount of vitamin E is expressed in
international units (IU). Two mg of a-tocopherol is considered equivalent to 3 IU (DuttaRoy et al., 1994).
Vegetables and seed oils are the primary sources of the tocopherols, whereas animal
products are generally poor sources of this vitamin (Budowski and Sklan, 1989).
Absorption of vitamin E is dependent upon digestion and absorption of fat. Free
tocopherols are absorbed by a non-saturable passive process into the lymphatic circulation.
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Approximately 45% of a given dose is absorbed into the lymph, while metabolites and a
small amount of the intact form of vitamin E are absorbed through the portal vein. Vitamin
E is transported in the blood principally by low-density lipoprotein (LDL) and high-density
lipoprotein (HDL; Dutta-Roy et al., 1994). Newly absorbed vitamin E accumulates largely
in adipose tissue, liver and muscle. The recommended dietary allowance (RDA) of vitamin
E for men and women is 10 and 8 mg/person/day, respectively (Meydani, 1995). Relative
to other fat soluble vitamins, vitamin E is safe. Few side effects have been reported, even
at doses as high as 3200 mg daily.
The most widely accepted biological function of vitamin E is its antioxidant property
(Dutta-Roy et al., 1994). Vitamin E is the most effective chain-breaking lipid-soluble
antioxidant in the biological membrane, where it contributes to membrane stability (DuttaRoy et al., 1994). It protects critical cellular structures against damage from oxygen free
radicals and reactive products of lipid peroxidation (Deshpande et al., 1996). Vitamin E
may participate in several events associated with the pathogenesis of cardiovascular
disease (CVD), including LDL oxidation, adhesion of monocytes to endothelial cells,
foam-cell formation and fatty-streak development, platelet adherence and aggregation,
smooth muscle cell proliferation, and reperfusion injury (Meydani, 1995). The limited
epidemiological studies available show an inverse relationship between dietary intake of
vitamin E and risk of CVD (Meydani, 1995). Several experimental and epidemiological
studies also suggest that vitamin E may reduce the risk of cancer. Vitamin E inhibits
mutagenesis and cell transformation primarily through its antioxidant function, eliminating
oxygen free radicals and decreasing DNA damage (Meydani, 1995).
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In addition to its antioxidant function, vitamin E influences cellular responses to
oxidative stress through the modulation of signal-transduction pathways (Azzi et al.,
1992). Evidence from cell-culture studies (Azzi et al., 1992) indicates that when cell
growth is inhibited by lipid peroxidation a-tocopherol may restimulate cell growth and
proliferation by removing the inhibitor. Conversely, it may also inhibit growth of cells
through its non-antioxidant properties: a-tocopherol inhibits protein kinase C activity, a
signaling element that can regulate cell proliferation (Azzi et al., 1992). The specific
inhibitory effect of a-tocopherol, but not of other tocopherols, on cell proliferation is
dependent on the type of the cell and the stimuli used. Under oxidative stress conditions,
diminution of a-tocopherol from smooth muscle cells results in growth and proliferation
of these cells which could contribute to the development of atherosclerosis (Deshpande et
al, 1996). The a-tocopherol modulation of signal transduction could also contribute to
the anticancer and immuno stimulatory effects of vitamin E (Meydani, 1995).
Reproductive failure in the rat was the first vitamin E deficiency syndrome described
(Evans and Bishop, 1922). Anemia is a characteristic symptom in vitamin E-deficient
monkeys (Fitch, 1968) and piglets (Baustad and Nafsted, 1972). Deficiency diseases in
human adults caused by insufficient intake of dietary vitamin E are extremely rare because
of the ubiquitous distribution of the vitamin. However, two groups of individuals are
susceptible to severe hypovitaminosis E. These are neonates and patients with disorders of
fat absorption or transport (Budowski and Sklan, 1989).
In chronic liver diseases, chronic cholestasis, cystic fibrosis and ileal resection,
circulating tocopherol levels are usually very low (Budowski and Sklan, 1989). Patients
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develop neurological symptoms, sometimes accompanied by muscular weakness. There is
strong evidence that vitamin E deficiency is responsible for this neuropathy, and massive
oral doses or intramuscular administration of vitamin E have been shown to relieve the
neural symptoms (Muller et al., 1983; Nelson, 1983). It appears that vitamin E deficiency
in humans primarily affects the central and peripheral nervous systems.
The cells of the immune system are highly susceptible to the harmful effects of freeradical reactions. Vitamin E , as the major vitamin antioxidant in plasma and tissue,
protects immune cells from these harmful effects. Deficiency in vitamin E is associated
with a decline in the immune response, whereas higher than recommended levels of
vitamin E have stimulatory effects on the immune system. In a double-blind study
examining the effects of vitamin E on immune responses, Meydani et al. (1989) found
significant improvement in several clinical indicators of immune function in healthy
subjects 60 years of age and older. Studies of murine AIDS suggest that vitamin E
supplementation acts on various immune components to modify immune defects induced
by retrovirus infection and that vitamin E effectively alleviates nutrient deficiencies
induced by retrovirus infection in the immune organs (Wang et al., 1994). High doses of
vitamin E were shown to increase humoral antibody production against particulate and
soluble antigens in different animal species and to enhance phagocytosis (Tengerdy, 1980).
Cell-mediated immune function was also stimulated by high dietary levels of vitamin E in
several experimental animals (Corwin and Schloss, 1980; Bendich et al., 1983; 1984;
1986). The beneficial effects of vitamin E on immune function may be attributed to the
inhibition of the production of certain immunosuppressive prostaglandins (Tengerdy,
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1980) or moderation of granulocyte activation (Deshpande et al., 1996). The protective
effect of vitamin E, therefore, may be associated with a reduction in the H 2 0 2 generated by
phagocytic cells of the immune system (Deshpande et al., 1996).
Selenium
Selenium is a component of several enzymes, in particular those related to redox
reactions. It was found to be an integral part of the antioxidant enzyme, glutathione
peroxidase, which protects cells by reducing intracellular peroxides (Spallholz, 1994). As
an antioxidant mineral, both deficiency and excess were found to have deleterious effects
on several animal body systems, including the immune system (WHO, 1987). Dietary
sources of selenium include cabbage, celery, radishes, brewer's yeast, fish, whole grains,
and meat. Selenium is present in organic form in these sources and the organic form is the
major nutritional source of selenium for animals and humans (Madhavi et al., 1996).
Ricettl and coworkers (1994) reported the effects of selenium (Se) supplementation
on glutathione peroxidase (GSH-Px) activity, on prostacyclin (PGI2) production, and on
GSH-Px mRNA expression in cultured human umbilical vein endothelial cells (HUVEC).
Se-enriched HUVEC showed a significant increase in both GSH-Px activity and thrombinstimulated production of PGI2. On the other hand, an inverse correlation was observed
between Se concentrations in culture media and GSH-Px mRNA levels in Northern blot
analysis. These results suggested that a major degree of regulation for GSH-Px expression
by Se was most likely exerted at the post-transcriptional level. Selenoprotein P is another
plasma selenoprotein and is a major participant in selenium metabolism (Burk and Hill,
1994). When the supply of selenium is limiting, selenoprotein P synthesis has priority over
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glutathione peroxidase synthesis (Burk and Hill, 1994). Selenoprotein P has been purified
from human plasma. In selenium deficient humans, selenoprotein P concentrations are low
(Burk and Hill, 1994). The proposed functions of selenoprotein P are in oxidant defense
and in the distribution of selenium throughout the body. However, the possibility of
antioxidant protection provided directly by selenoprotein P must be further investigated.
Selenium deficiency is associated with the development of two diseases, both of
which are only seen in China where acutely low soil levels of the selenium are reflected in
very low blood levels. Keshan Disease is a cardiomyopathy of children and young adults
(Xia et al., 1989), and Kachin Bech disease is an osteoarthropathy that occurs primarily in
young people (WHO, 1987). Both diseases are preventable by therapy with selenium
supplementation. But several features of the diseases suggest that they are not simple
selenium deficiency diseases; rather, they are multifactorial in origin, and selenium
deficiency is a major factor in their etiology (WHO, 1987).
There is a growing body of strong epidemiological evidence that shows a correlation
between low dietary intake of selenium and an increased risk of some cancers. A recent
study showed that selenium, but not other antioxidants, may help protect against ovarian
cancer (Stenson, 1996). In another study, the effect of selenium on murine tumor
formation was observed; the results showed that selenium was anticarcinogenic both in
vivo and in vitro. Dietary supplementation with 2.0 ppm selenium markedly inhibited
DMBA-induced mammary carcinogenesis, and this level of selenium was not significantly
detrimental to the normal physiological functions of the host (Medina et al., 1983). The
mechanisms involved in the protective effect of selenium in mammary tumorigenesis may
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be at the level of DNA synthesis because selenium exposure leads to DNA fragmentation
and increased mutagenesis in tumor cells. This effect is not attributable to GSH-Px
activity.
The effects of selenium deficiency have been studied in bacterial, yeast, parasitic and
viral infections. Selenium deficiency impaired the ability of mouse neutrophils to kill
Candida albicans in vitro, and thus selenium deficient mice were susceptible to C.
albicans (Boyne and Arthur, 1986). In contrast, selenium deficiency was shown to
increase the resistance of rats to Salmonella typhimurium (Boyne et al., 1984) and the
resistance of mice to Plasmodium bergeii, Listeria monocytogenes and Pseudorabies
virus (Boyne and Arthur, 1986).
A number of studies have documented that the availability of selenium in the diet
affects the immune functions of a host in vivo and that selenium deficiency and selenium
supplementation correlate, respectively, with a decreased or increased response of a host
to challenge with foreign antigens.
HIV infection results in poor oral uptake and gastrointestinal malabsorption, which
results in selenium deficiency. Diminished levels of Se are seen in both blood and tissue
(Dworkin, 1994). Patients with AIDS tend to have a more severe deficit in Se than those
with earlier stages of HIV infection. It has been suggested that in patients with AIDS,
selenium deficiency may be associated with myopathy, cardiomyopathy and immune
dysfunction including oral candidiasis, impaired phagocytic function and decreased CD4+
T-cells (Dworkin, 1994). Thus, Dworkin (1994) has suggested that selenium along with
other nutrients must be considered in the nutritional therapy of AIDS patients.
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Selenium supplementation significantly increased immunoglobulin M and G antisheep red blood cell hemagglutinating titers in Swiss Webster mice while Se toxicity or Se
deficiency resulted in titers approximately equal to or less than control mice (Spallholz et
al., 1973). Roy et al. (1994) studied the effect of supplementation with selenium on human
immune cells. Dietary supplementation of Se-replete humans with 200 ug/day of sodium
selenite for 8 wk, or in vitro supplementation with 1 x 10"7 M Se (as sodium selenite),
resulted in a significant augmentation of the ability of peripheral blood lymphocytes to
respond to mitogen or alloantigen and to express high affinity IL-2 receptors (IL-2R) on
their surface. Supplementation with Se could apparently modulate T-lymphocyte-mediated
immune responses in humans that depend on signals generated by the interaction of IL-2
with IL-2 R. Also, Se supplementation resulted in a 118% increase in cytotoxic
lymphocyte-mediated tumor cytotoxicity and an 82.3% increase in natural killer cell
activity as compared to baseline values (Kiremidjian-Schumacher et al., 1994). This result
was also correlated with the expression of high affinity IL-2 R, and consequently the rate
of cell proliferation and differentiation into cytotoxic cells was enhanced. The results
indicated that the immunoenhancing effects of selenium in humans require
supplementation above levels produced by normal dietary intake. In a follow-up study,
Roy and coworkers (1995) demonstrated that supplementation with selenium resulted in a
significant increase in the ability of splenic lymphocytes from aged male C57B1/6JNIA
mice to undergo blastogenesis, as indicated by significantly higher amounts of nuclear
incorporation of 3H-thymidine after stimulation with mitogen. It was also found that
dietary supplementation with Se restored the age-related deficiency of the cells to respond
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to mitogen stimulation by nuclear DNA synthesis and cell proliferation, at least to the level
of cells from unsupplemented young adult mice. Roy et al. (1995) also studied the effect
of Se in vitro, and the results showed that alloantigen-activated lymphocytes from Sesupplemented aged mice contained significantly higher numbers of cytotoxic lymphocytes
than those from Se-normal aged mice, which resulted in an enhanced capacity to destroy
tumor cells. This study verified again that the increased number of high-affinity IL-2R
resulted in cell proliferation when Se restored the age-related defect in immune cell
function.
The combined effect of vitamin E and selenium
As antioxidants, either vitamin E or selenium can protect fully against certain
diseases in animals such as liver necrosis in rats or exudative diathesis in chicks (Hoekstra,
1975). However, selenium cannot substitute for vitamin E in some other conditions, such
as fetal resorption in rats or encephalomalacia in chicks. It is thought that even under
conditions of adequate dietary selenium intake, glutathione peroxidase could not
sufficiently protect the target tissues (Levander, 1992). Selenium and vitamin E in
particular appear to have overlapping and synergistic functions.
Williams et al. (1994) studied the interaction of vitamin E and selenium in mice
resistant to virus-induced myocarditis. C57B1/6J mice fed a normal diet were resistant to
coxsackievirus B3 (CVB3) induced myocarditis. In this study, C57B1/6J mice were fed one
of four experimental diets. After consuming the diets for 4 weeks, mice were inoculated
with a myocarditic strain of CVB3. Ten days post inoculation, mice fed diets deficient in
both Se and vitamin E developed myocardial lesions consisting of an inflammatory

18

infiltrate. Mice fed adequate diets or diets singly deficient in either Se or vitamin E did not
develop myocarditis. Mice fed the double-deficient diet showed more severe myocarditis
than singly deficient-fed mice by developing glucosuria and elevated heart viral titers.
These results suggested an interaction of dietary vitamin E and selenium in determining the
outcome of infection with CVB3.
Murine malaria appears to be a useful experimental model for investigating
interrelationships of selenium and vitamin E because the malarial parasite is highly
susceptible to oxidative stress. In a study performed by Levander (1992), vitamin E
deficiency was found to protect against the parasitic infection while selenium deficiency
had little or no protective effect against the parasite. This study indicated that nutritional
manipulation of host antioxidant status may provide a promising prophylactic and/or
therapeutic tool for the control of malaria.
In a study of experimental diabetes in rats, the combination of selenium and vitamin
E showed an optimal effect in the delay of nephropathy (Douillet et al.,1996). Three
groups of diabetic rats were supplemented either with a Se-rich yeast diet (selenion),or
with selenomethionine, or with a double supplementation with selenomethionine and
vitamin E. These treatments led to an increase in selenium levels in plasma in the three
groups as compared with the unsupplemented diabetic group or the control group without
disease. These investigators concluded that combined treatment with Se and vitamin E
provided the most beneficial effect in protecting kidneys in diabetic rats with expression in
a significant correction of renal hyperfiltration and in a diminution of the number and
severity of glomerular lesions.
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Vitamin E and selenium have immunostimulatory effects in a variety of species when
administered in quantities in excess of established dietary requirements (Sheffy and
Schultz, 1979). Conversely, deficiencies in vitamin E and selenium lead to suppression of
immune responses, particularly cell mediated mechanisms. The responses to each of the
nutrients appear to be independent.
A combined deficiency in vitamin E and selenium in young chickens resulted in
histopathology of primary lymphoid organs, depressed humoral response to T celldependent antigens, reduced mitogenic responses of lymphocytes and impaired
macrophage function (Dietert et al., 1990). Further studies of cell surface marker
expression in chickens showed that vitamin E and selenium deficiency may negatively
affect both the maturation of specific lymphocyte subpopulations and the functional and
proliferative capabilities of the peripheral lymphocytes (Chang et al., 1994).
In a study of channel catfish (Wise and Tomasso, 1993), intracellular superoxide
anion production of macrophages was higher in fish fed a diet fortified with four times the
recommended levels of both vitamin E and selenium than in fish fed other diets (a diet
deficient in both nutrients; a diet deficient in either Se or vitamin E; and a diet adequate in
both nutrients). These results indicated that Se and vitamin E could not compensate for
each other and that the combined supplementation with both antioxidants greatly enhanced
macrophage function.
Dietary supplementation of mammals with vitamin E and Se is important in the
maintenance of host defense mechanisms, including antibody production, cell proliferation,
cytokine production, prostaglandin metabolism, and neutrophil function (Deshpande et al.,
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1996). Hogan et al. (1993) reported that there was a synergistic effect of vitamin E and Se
on the duration of clinical mastitis in cows. Cows supplemented with both vitamin E and
Se experienced a shorter duration of clinical signs than cows supplemented with either
nutrient alone. Neutrophils are very important in the host defense against bovine bacterial
infection. Dietary supplementation with vitamin E and selenium successfully optimized
neutrophil responses resulting in increased resistance to the bacteria which caused mastitis.
The effect of vitamin E and selenium on the immune response also has been
investigated in sows (Wuryastuti et al., 1993). The results of this study showed that the
phagocytic ability of colostral polymorphonuclear (PMN) cells was diminished
significantly only in the cells from sows deficient in both vitamin E and selenium. The
ability of peripheral blood PMN to engulf yeast cells in vitro was impaired by both vitamin
E and Se deficiencies and was impaired sooner by the combined deficiency than by
individual deficiency.

INTRODUCTION
During the past two decades, global epidemiological studies have been targeted at
uncovering the causes of several important diseases afflicting humans. These studies have
clearly demonstrated that many diseases, especially chronic diseases that affect humans,
have an uneven geographic distribution (Weisburger, 1991). Economics or local dietary
habits are often important contributing factors leading to the uneven geographic
distribution of these diseases. Epidemiological studies linking the prevalence of certain
diseases to dietary patterns often tend to show an inverse correlation between the
consumption of certain foods and the occurrence of certain diseases (Deshpande et al.,
1996).
Chagas' disease is a severe parasitic disease that is prevalent throughout Central and
South America. At the present time it is regarded as a major cause of morbidity and
mortality in tropical areas, particularly among the poor in developing nations (Kirchhoff,
1993). Many people in these areas are undernourished or malnourished (Foster, 1992),
and many children (especially those under the age of five) die of diseases either caused or
complicated by undernutrition (Foster, 1992). Generally speaking, a sufficient diet is
important for human health, especially for children and young adults because of their rapid
growth rate. Acute Chagas' disease is most severe in children under five years of age, and
most new infections in rural areas occur in young children (Kirchhoff, 1993).
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Although Chagas' disease is not caused by malnutrition, the uneven distribution of this
disease in Latin America suggests that nutrition and other socioeconomic factors may play
a role in this vector-borne parasitic infection.
Antioxidants have been studied for many years, and their function in disease
prevention has been recognized. The antioxidant activities of vitamin E and selenium in
particular have been studied in a variety of species (Hoekstra, 1975; Levander, 1992). At
the biochemical level, primary defenses against free radical mediated cell damage involving
the major enzyme systems and their substrates are supported by secondary defenses.
Selenium is an essential nutrient with antioxidant properties and is necessary for the
synthesis and activity of glutathione peroxidase, a primary cellular antioxidant enzyme in
the primary defense (Deshpande et al., 1996). Vitamin E is the principle component of the
secondary defense against free radical mediated cellular injuries. In fact, it is the only
natural, physiological, lipid-soluble antioxidant that can inhibit lipid peroxidation in cell
membranes (Budowski and Sklan, 1989). Thus, vitamin E and selenium play separate but
interrelated roles in the cellular defense against oxidative damage. Also, both vitamin E
and selenium have been shown to have immunostimulatory effects in a variety of species
when administered in quantities in excess of established dietary requirements (Sheffy and
Schultz, 1979). Deficiency in or supplementation with these two antioxidants has been
shown to affect the course of a variety of diseases or to have some clinical therapeutic
effects.
Studies of host cell invasion by Trypanosoma cruzi, the etiological agent of Chagas'
disease, have suggested that macrophages in host tissue play an important protective role
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against the parasite (Burleigh and Andrews, 1995). Activated macrophages are able to kill
intracellular trypomastigotes or amastigotes by toxic oxygen intermediates and nitric
oxide. However, the respiratory burst and the production of nitric oxide by macrophages
also may cause damage to surrounding host cells. As antioxidants, vitamin E and selenium
can help to protect cells from the damage caused by reactive oxygen intermediates. Under
conditions of normal nutrition, vitamin E and selenium levels in the diet should be
adequate to provide a certain level of protection against reactive oxygen intermediates
generated during T. cruzi infection. However, it seems likely that individuals who subsist
on diets deficient in one or both of these antioxidants may be more susceptible to the
severe pathological consequences of Chagas' disease. Vegetable and seed oils are the
primary nutritional source of vitamin E (Deshpande et al., 1996), while meat products are
good dietary sources of selenium (WHO, 1987). In the poor area of Latin America, where
typical diets may be lacking in these kinds of foods, individuals may well be deficient in
vitamin E or selenium as well as other antioxidant micronutrients. It is; therefore, of
interest to determine if there is a protective effect associated with dietary supplementation
with vitamin E and selenium during infection with T. cruzi.
The present study was designed to determine the combined effect of dietary
supplementation with different doses of vitamin E and selenium during experimental
Chagas' disease. The effect was observed by measuring weight, parasitemia, antibody
production and mortality. The optimal combination dose of vitamin E and selenium was
also determined.

MATERIALS AND METHODS
Parasites
The Brazil strain of Trypanosoma cruzi was used in all experiments. The parasites
were maintained by serial passage into C3HeB/FeJ mice at 3 week intervals. An infection
inoculum of 1 x 103 blood-form trypomastigotes (BFTs) in 0.2 ml of sterile Dulbecoo's
phosphate buffered saline (DPBS; Sigma Chemical Co., St. Louis, Missouri) was
administered intraperitoneally to each mouse.
Mice and diets
In the first phase of the study, 25 female C3HeB/FeJ mice (Jackson Laboratories,
Bar Harbor, Maine) were maintained at room temperature (26°C). The mice were five-six
weeks old upon arrival and were immediately placed on one of the diets described below.
Pelleted food and distilled water were provided ad libitum. The mice were randomly
separated into five cages of 5 mice each and were given food containing varying amounts
of vitamin E (Vit E) without selenium as follows: Cage 1 - 0 IU/kg Vit E; Cage 2 - 200
IU/kg Vit E; Cage 3 - 400 IU/kg Vit E; Cage 4 - 600 IU/kg Vit E; Cage 5 - 800 IU/kg Vit
E (Purina Mills, Richmond, Indiana). Mice were infected three weeks after being placed
on the experimental diets.
In the second phase of the study, 20 female C3HeB/FeJ mice (5-6 weeks of age)
were randomly separated into four cages of 5 mice each and were given food containing
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400 IU/kg Vit E (optimal dose determined from the first phase of the study). Drinking
water containing different doses of sodium selenate (Se; Sigma Chemical Co.) was given
as follows: Cage 1 - 2 ppm Se; Cage 2 - 4 ppm Se; Cage 3 - 8 ppm Se; Cage 4 - 1 6 ppm
Se. Mice were infected three weeks after being placed on the experimental diets. Food and
drinking water were provided ad libitum.
Parasitemia
Parasite counts were conducted twice weekly beginning on day 12 post-infection. A
4 f-il sample of blood was taken from the tail of each mouse and was diluted with 96
DPBS to make a 1/25 dilution. A hemacytometer (Fisher Scientific, Pittsburgh,
Pennsylvania) was used to count the parasites.
Weight and mortality
The mice were weighed on the first day of arrival and on the day before they were
infected with T. cruzi. Mice were then weighed on days 14, 28 and 42 of infection.
Mortality was monitored throughout the course of the experiments.
Trypomastigote antigen preparation
Fibroblast-derived trypomastigotes of the Brazil strain were cultured in PSC3H
murine fibroblasts (Gooding, 1977) infected with BFTs of T. cruzi. The cells were
cultured at 36°C in RPMI 1640 medium (HEPES modification; Sigma Chemical Co.)
adjusted to pH 7.2 and supplemented with penicillin G (100 units/ml), streptomycin (100
mg/ml) and 10% fetal bovine serum in a 5% C0 2 incubator. Culture supernatants
containing trypomastigotes were collected and filtered through Whatman #1 filter paper
(Jacobson et al., 1992). The filtered supernatants were then centrifuged for 20 minutes at
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1800 x g. The pellet, containing parasites, was resuspended in 1 ml ofDPBS, and
centrifuged for 5 minutes at 5000 x g. Following 2 additional washing steps, the pellets
were combined and resuspended in ice-cold DPBS containing 0.5% Triton X and 2 mM
phenylmethylsulfonyl fluoride (Sigma Chemical Co.). Parasite lysis and detergent
solubilization were achieved by frequent vortexing during a 30 minute incubation period
on ice. The resulting suspension was spun at 5000 x g for 15 minutes to remove insoluble
material and the supernatant was collected. A Bio-Rad protein assay (Bio-Rad
Laboratories, Hercules, California) was performed to determine the protein concentration
of the antigen preparation using bovine serum albumin as a standard. The antigen extract
was diluted to a working concentration of 25 Aig/ml in DPBS for use in an indirect enzyme
linked immunosorbent assay (ELISA).
Parasite-specific antibody levels
Individual wells of 96 well microtiter plates (Falcon Micro Test III; Becton
Dickinson, Oxnard, California) were incubated with 50 [A of parasite antigen (25 Aig/ml) at
room temperature overnight and were then stored at -70 °C until use. All mice were bled
on days 20 and 35 post-infection. A 20 jil sample of blood was taken from the tail of each
mouse and was diluted in 180 |il ofDPBS. Diluted blood was then centrifuged for 10 min
at 8,000 x g and the supernatant was removed and stored at -70°C until use. Normal
mouse plasma, prepared in the same manner, was used as a control in the enzyme-linked
immunosorbent assay (ELISA). The T. cruzi antigen-coated plates were blocked for 1 h at
room temperature with 2.5% nonfat dry milk (Carnation Co., Los Angeles, California) in
DPBS. Following the blocking step, the plates were washed 3 times in DPBS. A 100 /A

aliquot of the plasma sample for each infected mouse was added to the first well of each
row of the plate in duplicate and a two-fold serial dilution (in DPBS) of the plasma was
performed across each row. The dilution of plasma in the first well of each row was 1/55.
The plate was incubated for 2 h at 37°C. Following 4 washes in DPBS, 100 [A of the goat
anti-mouse immunoglobulin (IgG, IgM, IgA) conjugated to horseradish peroxidase (Sigma
Chemical Co.) was placed in each well of the plate at a dilution of 1:1000 in the blocking
solution and the plate was incubated for 1 h at 37°C. After a final washing step in DPBS,
the substrate O-phenylenediamine (Sigma Chemical Co; 30 mg), dissolved in 11.5 ml of
Tris-citrate buffer (pH 6.0) and activated with 30% hydrogen peroxide (H202; 10 /A in 1
ml H 2 0), was added to all wells of the plate (50/zl/well). The absorbance of each well of
the 96 well microtiter plate was measured at a wavelength of 490 nm with a Model 550
microplate reader (Bio-Rad Laboratories). Antibody titers were determined according to
the following equation: titer = highest dilution of the test plasma in which the absorbance
is > 0.05 and > the mean control absorbance + 2 standard deviations (SD).
Statistical analysis
Data were analyzed using SYSTAT (SYSTAT, 1992). Canonical variates analysis
(CVA) was used to test for differences among Vit E treatment groups in the first phase of
the study and among groups given different doses of selenium in conjunction with an
optimal dose of Vit E in the second phase of the study. Variables included in CVA are
Peakday, Firstday, Meanpeak, Peakvalue, Antibody, Weight 1, Weight 14, Weight 28.
Peakdav refers to the day on which individual mice have the highest number of parasites in
the peripheral circulation. Firstday refers to the first day on which parasites were detected
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in the blood of individual mice. Meanpeak refers to the number of parasites on the day that
was the average value of the Peakdays of all mice in one treatment group. Peakvalue
refers to the highest number of parasites in the blood of individual mice. Antibody refers to
the absorbance of individual plasma samples in the first dilution (1/55) of ELISA. Weight
1, 14, 28 refers to weight of individual mice on the day before infection, day 14 and day
28, respectively. To separate effects of Vit E deficiency from those of different doses of
Vit E, two CVA, one including all Vit E treatment groups and the other excluding Vit E
deficient group, were conducted in the first phase of the study. The 0 ppm Se plus 400
IU/kg Vit E treatment group in the first phase of the study served as the Se-deficient
control group for the second phase of the study. Mortality data could not be included in
the CVA because only one value (i.e., percent survival) is obtained for each treatment
group.

RESULTS
Effect of vitamin E supplementation on weight
The weights of all mice were measured on days 14 and 28 post-infection and the
results are shown in Figure 1. Mice in the Vit E deficient group showed the greatest loss
of average weight among all groups from day 14 to day 28 of infection. The percent loss
per kilogram average weight for this group was nearly two fold greater than that of any
Vit E supplemented group (Table la; 23.15% versus 8.7-12.20%). Among Vit E
supplemented groups, the 800 IU/kg Vit E treatment group showed the least average loss
of weight followed by the 400 IU/kg Vit E treatment group. However, as shown in Figure
1, the data for the 800 IU/kg Vit E treatment group showed a larger standard deviation
than the 400 IU/kg Vit E treatment group. The average weight on day 42 of infection is
not shown due to mortality.
Effect of vitamin E supplementation on parasitemia
Mean parasitemia levels for each treatment group of mice are shown in Figure 2. The
400 IU/kg and 600 IU/kg Vit E treatment groups had lower parasitemias than the other
three Vit E treatment groups, while the 800 IU/kg Vit E treatment group showed the
highest parasitemia levels. Parasitemia values for the vitamin E deficient group were
intermediate between the parasitemia values observed for the 200 IU/kg Vit E treatment
group and the 400 IU/kg Vit E treatment group.

29

30

Effect of vitamin E supplementation on mortality
Dietary supplementation with Vit E (even in the absence of selenium) resulted in
increased longevity and survival in infected mice. As shown in Figure 3, despite only
moderately high parasitemia levels, the Vit E deficient group showed 100% mortality by
day 43 post-infection. In contrast, by day 48 of infection the 400 IU/kg treatment group
had the highest survival rate (80%) followed by the 600 IU/kg treatment group which had
a survival rate of 40%. On day 53 of infection, the 400 IU/kg Vit E treatment group
showed a survival rate of 60%, while the 600 IU/kg and 800 IU/kg Vit E treatment
groups showed 20% and 0% survival, respectively. At the end of the first phase of the
study (day 70 post-infection), the 400 IU/kg and 600 IU/kg Vit E treatment groups
showed 20% survival while all other treatment groups exhibited 0% survival.
Parasite-specific antibody response in phase I
Antibody levels for each Vit E treatment group are shown in Figure 4. Antibody
levels were similar for all treatment groups, although mice in the 600 IU/kg Vit E
treatment group showed the highest absorbance values at all dilutions in the assay on day
20 of infection. There was no statistically significant difference in parasite-specific
antibody levels between different Vit E treatment groups on day 20 or on day 35 of
infection (p > 0.05). Parasite-specific antibody titers obtained from ELISA results are
listed in Table 2a and 2b. The highest antibody titer was observed in the 600 IU/kg Vit E
treatment group on day 20.
Statistical analysis in phase I
The overall effect of the Vit E treatments differed significantly among groups (F 3212
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= 3.866, p = 0.007). Vit E deficient mice were significantly different from all Vit E
supplemented groups (Test of residual roots X 2 = 65 .75, df = 32, p < 0.001). There was
no statistically significant difference among Vit E supplemented groups (Test of residual
roots X 2 = 28.98, df= 21, p = 0.114). Weight 1 and Weight 14 load heavily on canonical
variate I (Fig. 5a) and thus are major contributors to the differences among treatment
groups on that axis. The Vit E supplemented groups had lower weights than the Vit E
deficient group on both the day before infection and on day 14.
Effect of selenium and vitamin E supplementation on weight
Weights of all mice were measured in the second phase of the study on days 14, 28,
and 42 of infection. Figure 6 shows that the 0 ppm Se treatment group had the greatest
loss of average weight among all treatment groups from day 14 to day 42 of infection. The
percent loss per kilogram average weight of this group was at least 3 fold greater than
that of any Se supplemented group from day 14 to day 42 (Table lb; 28.05% versus 0.958.91%). Among the Se supplemented groups, the 8 ppm Se treatment group showed the
least loss of average weight from day 14 to day 42 of infection. The 2 ppm and 8 ppm Se
treatment groups actually showed a percent weight gain between day 14 and day 28 of
infection.
Effect of selenium and vitamin E supplementation on parasitemia
Parasitemia levels measured in the second phase of the study are shown in Figure 7.
The 8 ppm Se plus 400 IU/kg Vit E treatment group had the lowest mean parasitemia
(1.44xl06/ml) at its peak. In contrast, the Se deficient group exhibited the highest peak
parasitemia (2.72><106/ml) among all treatment groups. The second highest peak
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parasitemia (2.45 x 106/ml) was observed in the 16 ppm Se treatment group.
Effect of selenium and vitamin E supplementation on mortality
Survival rates in the second phase of the study are shown in Figure 8. The 0 ppm Se
treatment group showed the lowest overall survival rate of 20%, whereas the 8 ppm and
16 ppm Se treatment group showed the highest survival rate of 80% by the end of the
second phase of the study (day 70 post-infection). Combined treatment with 400 IU/kg
Vit E plus 8 ppm Se or 16 ppm Se increased the survival rate of infected mice 4 fold
above that observed when mice were given 400 IU/kg Vit E in the absence of Se in the
first phase of the study.
Parasite-specific antibody response in phase II
The parasite-specific antibody levels for all Se plus Vit E treatment groups on day 35
of infection are shown in Figure 9. The antibody titers are given in Table 2c. Mice treated
with 400 IU/kg Vit E and Se showed antibody titers at least 4 fold higher than observed
on the same day of infection in the 400 IU/kg Vit E (0 ppm Se) treatment group.
However, statistical analysis indicated that there was no significant difference in the
parasite-specific antibody levels among different Se treatment groups. Compared with the
antibody data obtained in the first phase of the study on day 35 of infection, parasitespecific antibody titers of all but 16 ppm Se plus 400 IU/kg Vit E treatment groups were
at least 2 fold greater than observed in groups given only Vit E (Table 2b, 2c). Despite
these observed differences in antibody titer, there was no statistically significant difference
between Vit E plus Se treatment groups and the groups given Vit E only.
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Statistical analysis in phase II
The overall effect of Se plus 400 IU/kg Vit E treatment showed a statistically
significant difference among treatment groups (F40 28 = 2.898, p = 0.002). Both canonical
variate I (Test of residual roots X2 = 77.05, df = 40, p < 0.001) and canonical variate II
(Test of residual roots X 2 = 43.94, df = 27, p = 0.021) showed significant differences
among treatment groups. Weight 1, 14, and 28 were the primary contributing factors to
separation of groups on canonical variate I (Fig. 10). Meanpeak, Weight 14 and Weight
28 were main contributing factors in determining significant differences among Se
treatment groups on canonical variate II. Mice in the 16 ppm Se treatment group showed
the lowest weights on the day before infection and on days 14 and 28 of infection,
followed by mice in the 8 ppm Se treatment group. The 0 ppm Se supplemented group
showed the highest weights on the day before infection and on days 14 and 28. On
canonical variate II, the 4 ppm Se treatment group showed lower levels of parasites in the
blood and higher weights on days 14 and 28 of infection, followed by the 16 ppm and 8
ppm Se supplemented groups.
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TABLE 1. Weight loss of T. cruzi-infected mice with vitamin E supplementation (a) or
supplementation with selenium plus vitamin E (b). The loss of weight per kilogram
average body weight from day 14 to day 28 or from day 14 to day 42 was calculated for
each vitamin E treatment group (all with 0 ppm selenium) or each selenium plus vitamin E
(400 IU/kg) treatment group.
a.
Vit E Treatment (IU/kg)
with 0 ppm Se
% Loss day 14-28

0

200

400

600

800

23.15

11.23

9.63

12.20

8.70

0

2

4

8

16

9.63
28.05

-0.91
8.21

3.86
8.91

-3.42
0.95

0.57
3.42

b.
Se Treatment (ppm)
with 400 IU/kg Vit E
% Loss day 14-28
% Loss day 14-42
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TABLE 2. Parasite-specific antibody titers, a) Data are presented for vitamin E treatment
groups (all with 0 ppm selenium) on day 20. b) Data are presented for vitamin E treatment
groups (all with 0 ppm selenium) on day 35. c) Data are presented for selenium plus
vitamin E (400 IU/kg) treatment groups on day 35.
a.
Vit E Treatment (IU/kg)
with 0 ppm Se
Titer

0

200

400

1/7040

1/1760

1/1760

0

200

400

600

ioo"

1/56320 1/3520

_

Vit E Treatment (IU/kg)
with 0 ppm Se
Titer

600

800

1/3520 1/14080 1/3520 1/14080 1/14080

c.
Se (ppm) with
400 IU/kg Vit E
Titer

0

2

4

8

1/3520 1/28160 1/28160 1/28160

16

1/14080
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FIGURE 1. Effect of vitamin E supplementation on weight of T. crwzz-infected mice. The
average weight of individual T. cruzi-infected mice in each vitamin E treatment group (all
with 0 ppm selenium) was calculated on days 14 and 28 post-infection, respectively. Data
are presented as average weight + standard deviation of weights of five mice in each
group.
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FIGURE 2. Effect of vitamin E supplementation on parasitemia of T. cruzi-infected mice.
Points represent the mean number of blood-form trypomastigotes per milliliter of blood
(five mice per group; all with 0 ppm selenium). Standard deviations are not indicated to
preserve the clarity of the figure.
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FIGURE 3. Effect of vitamin E supplementation on mortality of T. crwz/'-infected mice.
The percent survival for each vitamin E treatment group (all with 0 ppm selenium) is
presented for different days post-infection.
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FIGURE 4. Plasma levels of parasite-specific antibody on day 20 (a) and on day 35 (b)
post-infection in mice infected with T. cruzi. All mice were treated with varying doses of
vitamin E without selenium. Levels of anti-J. cruzi antibodies were measured in unpooled
plasma collected from individual infected mice and pooled normal mouse plasma. Data are
presented as the mean absorbance (at 490 nm) of five plasma samples in each vitamin E
treatment group. Data obtained from normal mouse plasma are presented as the mean
absorbance ± 2 standard deviations of duplicate values.
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FIGURE 5. a) Multivariate analysis of the effects of different vitamin E treatments in
mice infected with T. cruzi. Mice (all with 0 ppm selenium) with high positive scores on
canonical variate I were characterized by high weights on the day before infection and day
14 (HW (1, 14) ), while those with negative scores on canonical variate I were
characterized by low weights on the day before infection and day 14 (LW (1, 14) ). b)
Multivariate analysis of the effects of different levels of vitamin E supplementation in mice
infected with T. cruzi. Mice with high positive scores on canonical variates analysis (CVA)
were characterized by high weights on the day before infection (HW (1) ), low weight on
day 14 (LW (14)) and high Peakvalue (H Peak), as well as late Firstday (Late Firstday),
while those with negative scores on CVA were characterized by low weights on the day
before infection (LW (1)), high weights on day 14 (HW (14) ) and low Peakvalue as well
as early Firstday (Early Firstday).
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FIGURE 6. Effect of selenium plus vitamin E supplementation on weight of T. cruziinfected mice. The average weight of individual T. cruzi-infected mice in each selenium
treatment group was calculated on days 14, 28 and 42, respectively. All mice were
administered 400 IU/kg vitamin E. Data are presented as average weight + standard
deviation of weights of five mice in each group.
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FIGURE 7. Effect of selenium plus vitamin E supplementation (400 IU/kg) on
parasitemia of T. cruzi-infected mice. Points represent the mean number of blood-form
trypomastigotes per milliliter of blood (five mice per group). Standard deviations are not
indicated to preserve the clarity of the figure.
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FIGURE 8. Effect of selenium plus vitamin E supplementation (400 IU/kg) on mortality
of T. cruzi-infected mice. The percent survival for each selenium treatment groups (all
with 400 IU/kg vitamin E) is presented for different days post-infection.
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FIGURE 9. Plasma levels of parasite-specific antibody on day 35 post-infection in mice
infected with T. cruzi. All mice were treated with different doses of selenium plus 400
IU/kg vitamin E. Levels of anti-T. cruzi antibodies were measured in unpooled plasma
collected from individual infected mice and pooled normal mouse plasma. Data are
presented as the mean absorbance (at 490 nm) of five plasma samples in each selenium
treatment group (all with 400 IU/kg vitamin E). Data obtained from normal mouse plasma
are presented as the mean absorbance ± 2 standard deviations of duplicate values.
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FIGURE 10. Multivariate analysis of effects of different doses of selenium with 400
IU/kg vitamin E on mice infected with T. cruzi. Mice with high positive scores on
canonical variates analysis were characterized by high weight on the day before infection,
days 14 and 28 as well as low Meanpeak, while those with negative scores were
characterized by low weight before infection, days 14 and 28 as well as high Meanpeak.

• • • , • • • , • • •

i

[

,

LMean
HW(14, 28)
A

D

A
A

- •
•

o

A

o

~

A

-

O
o

V

o o

V

HMean
o
LW(14, 28)
, , , 1, , , 1 , , ? 1, , , 1, , , 1, , ,
-6
-4
-2
0
2
4
6
Canonical Variate I
LW(1, 14, 28)
V
o
A

0 ppm Se with Vit E
2 ppm Se with Vit E
4 ppm Se With Vit E

HW(1, 14,28)
o
•

8 ppm Se with Vit E
16 ppm Se with Vit E

DISCUSSION
The results of the present study verify that antioxidants such as vitamin E and
selenium may have a beneficial effect during infectious disease. The combined effect of
dietary supplementation with these two micronutrients during experimental Chagas'
disease is reported here for the first time.
The results obtained from the first phase of the study demonstrate a significant
positive effect of Vit E on mice infected with T. cruzi (Fig. 5a). In this analysis, weights on
the day before infection and day 14 were contributing factors leading to the significant
difference mentioned above. The fact that these factors lost their advantage after day 14 in
Vit E deficient mice suggests that Vit E deficient mice lost more weight than Vit E
supplemented mice with the progression of T. cruzi infection. Because loss of weight is an
indication of the severity of disease, this observed increased weight loss indicates that Vit
E deficient mice are more susceptible to the pathological consequences of T. cruzi
infection than Vit E supplemented mice. This conclusion is further supported by the fact
that supplementation with 400 IU/kg and 600 IU/kg Vit E also led to decreased
parasitemia levels and increased longevity and survival rates. The C3HeB/FeJ mice used in
this study are highly susceptible to infection with the Brazil strain of T. cruzi and normally
die with high parasitemias by day 45 of infection when maintained on standard Purina
Rodent Chow. The increased longevity and low parasitemias observed in the 400 IU/kg
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Al
and 600 IU/kg Vit E treatment groups suggest that dietary supplementation with Vit E
above normal levels (45-75 IU/kg; Bendich, 1990) is beneficial during T. cruzi infection.
Vit E, as a lipid-soluble vitamin, is absorbed in the free form in the small intestine of
mammals (Budowski and Sklan, 1989). Mammalian transport of newly absorbed Vit E is
by substances known as chylomicrons which carry Vit E to the bloodstream and tissues via
the lymphatic system (Budowski and Sklan, 1989). In tissue, Vit E is concentrated in
membranes, including the mitochondrial, microsomal and plasma membrane (Krishnamurty
and Bieri, 1963; Bonnetti and Novello, 1976). Although blood and tissue levels of Vit E
were not measured in the present study, mice supplemented with Vit E normally achieve
elevated levels of Vit E in the blood and tissues. Thus, the result from detecting effects of
dietary supplementation with Vit E as used in the present study should be consistent with
that from detecting effects of Vit E in the blood and tissues.
Vit E supplementation has been shown to have a positive effect upon the immune
response, while deficiency in Vit E compromises the immune system (Wang and Watson,
1994). Vit E has been found to enhance the activity of T helper cells and to have a positive
impact on the antibody response, delayed cutaneous hypersensitivity reaction,
phagocytosis, mitogen responsiveness, the reticuloendothelial system, and host resistance
in a variety of animal models (Shefty and Schultz, 1979). A significant increase in
bactericidal activity in peripheral blood leukocytes has been observed in humans after
ingestion of 300 mg of Vit E daily for three weeks (Prasad, 1980). Vit E also has been
shown to increase IL-2 production in elderly subjects (Meydani et al., 1986). One of the
hallmarks of infection with T. cruzi is a profound suppression in the production of IL-2
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and in the expression of IL-2R (Majumder and Kierszenbaum, 1996). IL-2 is a pivotal
cytokine in the growth and differentiation of T and B cells. Although IL-2 levels were not
measured in the present study, it is possible that dietary supplementation with Vit E might
allow mice to compensate for the suppression in IL-2 production normally resulting from
T. cruzi infection. Based upon the results of earlier studies, it is also possible that Vit E
supplementation may lead to enhanced immunoglobulin production and improved T and B
cell proliferation during infection (Wang and Watson, 1994). In the present study, only
parasite-specific antibody levels were measured. Although differences were observed in
antibody titers, there was no statistically significant difference observed in parasite-specific
antibody levels between different Vit E treatment groups. Future studies will be required
to determine if other parameters of the humoral or cell-mediated immune response are
impacted by supplementation with Vit E.
The position of the 600 IU/kg Vit E treatment group in Figure 5b indicates that
parasites appeared later in this group than in the 400 IU/kg and 200 IU/kg Vit E treatment
groups. It also indicates that the 600 IU/kg Vit E treatment group had the highest weight
on day 14 and the lowest peak parasitemia among these four treatment groups. Even
though parasites appeared latest in the 800 IU/kg Vit E treatment group, the 800 IU/kg
group showed lower weight on day 14 and higher peak parasitemia than the 600 IU/kg
treatment group. Thus, the 600 IU/kg Vit E treatment group showed the best overall
effect. In the same analysis, the 400 IU/kg treatment group showed the second best overall
effect. Mortality data could not be included in the CVA because only one value (i.e.,
percent survival) is obtained for each treatment group. However, it is a very important
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factor when evaluating differences among treatment groups. The 400 IU/kg Vit E
treatment group showed the highest survival rate on day 53 of infection among all
treatment groups. Therefore, the 400 IU/kg was chosen as the optimal dose of Vit E to be
used in the second phase of the study based on mortality data and CVA results.
The results of the present study suggest that the immunostimulatory effect of Vit E is
apparent only when Vit E is administered in quantities in excess of normally recommended
levels. Mice in the 200 IU/kg Vit E treatment group showed a higher mean parasitemia
than mice in the Vit E deficient group (Fig. 2), which suggests that 200 IU/kg Vit E may
be not sufficient to impact the levels of circulating parasites in infected mice. The level of
Vit E present in standard rodent chow is 49 IU/kg (Purina, 1994). The 800 IU/kg Vit E
treatment group showed an overall higher mean parasitemia and an almost 3 fold higher
mean parasitemia at its peak than any other group. This result suggests that the 800 IU/kg
Vit E dose is above the optimal range of Vit E supplementation in this model system. In
short-term studies of Vit E toxicity in mice fed a-tocopherol at dose levels of 5% daily for
2 months, no adverse effects were observed (reviewed by Madhavi and Salunkhe, 1996).
In a second study performed by Dysmsza and Park (1975), rats were given 0.0035% and
25, 50, 100, 1000 times this concentration for a period of 13 weeks. Food intake and
protein efficiencies were found to be significantly reduced after the first 8 weeks.
However, there were no changes in hemoglobin levels, serum cholesterol levels or urinary
creatine levels. In a 13-week study in which Fischer 344 rats were administered atocopheryl acetate by gavage at levels of 125, 500 or 2000 mg/kg body weight per day, no
adverse effects were observed on food intake or body weight (Abdo et al., 1986). These
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results suggest that even high doses of Vit E are not generally toxic in experimental
animals. It is not clear why the 800 IU/kg Vit E treatment led to elevated parasitemias in
this study. One possibility may be that such high levels of Vit E were actually benefitting
the parasite. Levander et al. (1989) found that mice fed levels of Vit E as low as 100
IU/kg Vit E showed high parasitemias during infection with malarial parasite Plasmodium
yoelii. Plasmodium yoelii is particularly vulnerable to oxidative stress, and the authors
suggested that elevated levels of Vit E in the host diet might actually benefit the parasite
by allowing it to compensate for ROS production in the host.
The results from the second phase of the study demonstrate the positive effect of
combined Se and Vit E supplementation in mice infected with T. cruzi. Se and Vit E (400
IU/kg) supplemented mice showed lower mean parasitemias and higher survival rates than
mice supplemented with Vit E (400 IU/kg) in the absence of Se. This result suggests that
combined Vit E and Se supplementation greatly increases the resistance of mice to
infection with T. cruzi. A previous study in our laboratory indicated that Se
supplementation at levels ranging from 2 ppm to 16 ppm provided in drinking water led to
reduced parasitemias and increased survival rates in mice infected with T. cruzi
(unpublished observation). It was also found that 8 ppm Se provided the best positive
effect on mice infected with T. cruzi. The results of the present study confirm this
beneficial role for Se.
Se can be readily absorbed in the gastrointestinal tract, the respiratory tract and the
skin. Under normal conditions, levels of Se are higher in the kidney and liver than in the
other major body tissues (WHO, 1987). A plasma selenoprotein is responsible for Se
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transport (Motsenbocker and Tapple, 1982). In blood, Se is present as plasma selenium
and red blood cell-selenium. Dietary supplementation with Se is correlated with increased
levels of Se in the blood and tissues.
Spallholz et al. (1973) investigated the effect of dietary Se supplementation on the
immunological responses of mice. Mice on a laboratory chow diet (originally containing
0.5 mg selenium/kg) were supplemented with sodium selenite at 0.7 or 2.8 mg/kg.
Supplemented mice showed approximately 7 and 30 fold higher antibody titers,
respectively, as compared to mice fed the chow diet alone. Sodium selenite injected into
mice intraperitoneally at doses 3-5 (ig per animal also increased the primary humoral
response to sheep red blood cells, and this increase was greatest when the selenium was
given prior to, or simultaneously with, the antigen (Spallholz et al., 1975). The doses of Se
needed to enhance the immune response in this study were clearly above the normally
recommended levels.
In the present study, mice supplemented with 2 ppm, 4 ppm, 8 ppm and 16 ppm Se
(plus 400 IU/kg) showed parasite-specific antibody titers of 1/28160, 1/28160, 1/28160
and 1/14080, respectively. Compared with a titer of 1/3520 exhibited by mice in the Se
deficient group, Se supplementation did result in an enhancement of antibody production.
However, there was no statistically significant difference between the antibody levels of Se
deficient mice and those of Se supplemented mice. Further studies will be required to fully
evaluate the impact of Vit E and Se supplementation on humoral responses during
infection with 71 cruzi.
Mice supplemented with Vit E and Se showed large differences in weight,
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parasitemia, survival, and parasite-specific antibody titer as compared to mice
supplemented with Vit E only. Mice in 2 groups (2 ppm and 8 ppm Se supplemented
groups) even showed a weight gain on day 28 of infection while all other mice exhibited
weight loss by day 28 in the first phase of the study. All Se supplemented groups had
overall lower parasitemias than the Se deficient group, and all Se supplemented mice
showed a survival rate of 65% on day 70 of infection while all Se deficient mice showed a
survival rate of 10% on the same day of infection. In addition, the parasite-specific
antibody titers of Se supplemented groups (except for the 16 ppm Se supplemented
group) are higher than those observed for the Se deficient groups. These results indicate
that Vit E and Se have a combined positive effect when administered to mice during
infection with T. cruzi.
Vit E, as an intracellular antioxidant, prevents oxidative damage to polyunsaturated
fatty acids in biological membranes (WHO, 1987). It protects against oxidative stress
either by catalyzing the destruction of hydrogen peroxide or catalyzing the decomposition
of lipid hydroperoxides, thereby interrupting the free radical peroxidative chain reaction.
Se and Vit E show a synergistic effect in depressing lipid peroxide formation in vivo and
in vitro in an NADPH-dependent microsomal lipid peroxidation systems (Madhavi et al.,
1996). However, these two micronutrients have different antioxidative effects (Zhu et al.,
1992). Vit E prevents lipid peroxidation in biomembranes more effectively than Se; while
Se prevents free radical production in the cytoplasm as part of glutathione peroxidase as
well as protecting -SH groups present in membrane proteins against oxidation.
The exact mechanism by which Vit E and Se are able to enhance the resistance of
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mice to T. cruzi infection is not known. T. cruzi is an obligate intracellular parasite which
must invade host cells in order to replicate. The parasite is capable of invading almost any
nucleated cell in the body including cells such as macrophages and neutrophils. Activated
macrophages and monocytes produce tumor necrosis factor P (TNF-P) in response to
free-radical activity (Greenspan and Aruoma. 1994). TNF-P in turn increases the
production of additional ROS from macrophages and neutrophils and acts on T cells to
enhance the production of IL-2 and the expression of EL-2R, thereby promoting activation
of T-cell-respiratory activity and an increase in intracellular ROS (Greenspan and Aruoma,
1994). Also, activated macrophages can produce nitric oxide (NO), which may negatively
impact the DNA synthesis of neighboring cells, especially in lymphocytes and thymocytes
(Greenspan and Aruoma, 1994). Large quantities of ROS and NO may lead to severe
damage in cells surrounding activated phagocytes (Deshpande et al., 1996). Thus,
antioxidants are needed to remove these ROS and NO to protect host cells from oxidative
stress. In some disease states that are associated with high levels of oxidative stress, it
may be necessary to consume dietary antioxidants at levels greater than normally
recommended because a sufficient level of antioxidants must be present to completely rule
out the negative effects of ROS or NO.
ROS have been postulated to lead to cardiac injury both in animal models and in
humans (reviewed by Paraidathathu et al., 1994). Vit E supplementation has been shown
to reduce myocardial oxidative stress (Goldfarb et al., 1996). Thus Vit E supplementation
may be beneficial in the prevention of cardiac injury. One of the symptoms associated with
the chronic stage of Chagas' disease is damage to heart muscle cells. In the present study,
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mice given Vit E below 800 IU/kg showed increased longevity and reduced parasitemias.
It is possible that Vit E supplementation functions, in part, to protect the hearts of infected
mice from damage caused directly by parasites and by associated damage resulting from
oxidative stress. Future studies will be required to investigate this hypothesis.
The result of canonical variates analysis in the second phase of the study indicates
that there is a statistically significant difference among Se treatment groups (Fig. 10).
Mouse weights on the day before infection, day 14 and day 28, were major contributing
factors in this analysis. Although the 0 ppm Se treatment group showed the highest weight
on the day before infection, on day 14, and on day 28, this weight advantage was lost after
day 28. This result suggests that the 0 ppm Se treatment group lost more weight than the
other treatment groups with the progression of T. cruzi infection. The relative weight
advantage of the 16 ppm and 8 ppm Se treatment groups increased during infection even
though they showed lower weights than the 0 ppm Se treatment group at the beginning of
the experiment. Mice in the 8 ppm Se treatment group showed the lowest weight loss of
all treatment groups over the entire course of infection (Table lb). The 16 ppm and 8 ppm
Se treatment groups also showed low levels of circulating parasites. Although the 4 ppm
Se treatment group also showed low parasitemia levels, mice in this group showed a
greater weight loss than mice in the 16 ppm and 8 ppm Se treatment groups. These results
indicate that mice in the 16 ppm and 8 ppm Se treatment groups were most resistant to the
pathological consequences of the infection. According to the results of CVA, the 16 ppm
Se treatment appeared to provide the best overall effect followed by the 8 ppm Se
treatment. However, the 8 ppm Se treatment group showed the highest survival rate
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(100% on day 66) among all Se treatment groups. When mortality was considered
together with the results of CVA, the combination of 8 ppm Se with 400 IU/kg Vit E was
judged to provide the best overall beneficial effect during experimental Chagas' disease. In
rats, rabbits and cats the acute oral and intravenous LD50 of Se as sodium selenite or
selenate was found to be 1.5-3 mg per kilogram of body weight. Se also was found to be
toxic at higher doses (reviewed by Madhavi and Salunkhe, 1996). No dose of Se used in
the present study was found to be toxic.
In conclusion, the present investigation indicates that Vit E supplementation does
have a protective effect during infection with T. cruzi and that Vit E in combination with
Se is particularly valuable in providing enhanced benefit during experimental Chagas'
disease. The results of this study also suggest that 400 IU/kg Vit E and 8 ppm selenium
provide the best protective effect in this model of experimental Chagas' disease. Future
research should be focused on analyzing the histology of surviving mice following
antioxidant treatment and determining the mechanisms of protective antioxidant activity
during experimental Chagas' disease.
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